UC AKT.ANL. 12/24 OMV/ DE000HD1QP71 /
2024-11-15 9:45:14 PM | Chg.0.000 | Bid9:59:24 PM | Ask9:59:24 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
100.830EUR | 0.00% | 99.590 Bid Size: 60,000 |
102.160 Ask Size: 60,000 |
OMV AG | 32.3068 EUR | 2024-12-31 | Call |
GlobeNewswire
03-26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
01-16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
2023-09-14
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center